Jump to content
Powered by
  • BIOPRO BW
  • Healthcare industry
  • Bioeconomy

Healthcare industry

Main navigation

  • Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close
  • Databases

    Databases

    Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Article - 24/05/2010 11444_de.jpg

    Nose drops replace transplantation

    Dr. Lusine Danielyan a scientist from Tübingen has developed a method that enables her to administer therapeutic cells for the treatment of neurodegenerative diseases to animals without requiring syringes or surgery. The animals simply snort the cell suspension. In September 2009 Danielyan received the Baden-Württemberg Research Prize for Alternative and Complementary Methods to Animal Testing for her development.

    https://www.gesundheitsindustrie-bw.de/en/article/news/nose-drops-replace-transplantation
  • Article - 24/05/2010 View into an opened chicken egg. A tumour, applied to the outer membrane, which is criss-crossed with numerous blood vessels, has grown in a spherical area.<br />

    Alternative CAM: chicken eggs to precede mouse experiments

    Researchers who test whether in vitro results can be transferred to living organisms prefer to use mice rats or rabbits. Many questions can be answered using the chorioallantoic membrane CAM of fertilised chicken eggs an alternative model to animal experiments that provides rapid results and only costs 50 cents per egg.

    https://www.gesundheitsindustrie-bw.de/en/article/news/alternative-cam-chicken-eggs-to-precede-mouse-experiments
  • Article - 15/04/2010 11127_de.jpg

    Bone-hard basic research for an ageing society

    Osteoporotic bones not only break very easily, they also heal badly when a fracture occurs. A fractured femur neck might mean that elderly patients have to remain bedridden for a long period and maybe even need nursing care. Fractures that heal badly, in combination with other diseases, frequently lead to a fatal outcome. A panregional team of researchers, including researchers from Ulm, has been working together since 2007 on basic research into…

    https://www.gesundheitsindustrie-bw.de/en/article/news/bone-hard-basic-research-for-an-ageing-society
  • Article - 28/03/2010 10925_de.jpg

    Acrovis biostructures: because the beginning of a process is crucial

    Targeted substance design using an advanced platform technology that takes into account the natural dynamics of pharmaceutical substances and targets early on during the discovery process – this is what the Ulm-based biopharmaceutical company Acrovis biostructures GmbH offers. Acrovis has all the instruments needed to be able to optimally determine the structure of pharmaceutical substances.

    https://www.gesundheitsindustrie-bw.de/en/article/news/acrovis-biostructures-because-the-beginning-of-a-process-is-crucial
  • Article - 22/02/2010 10746_de.jpg

    Immune system discovers mould fungi through surface structures

    Mould fungus spores which are found in air aerosols are constantly being taken up in the air we inhale. As a rule this poses no danger to healthy people. However depending on the quantity of spores inhaled and the duration of exposure mould fungi could possibly lead or contribute to lung diseases and allergies. Dr. Mardas Daneshian and his team at the University of Constance are focusing on the immunostimulatory capacity of fungal spores. The…

    https://www.gesundheitsindustrie-bw.de/en/article/news/immune-system-discovers-mould-fungi-through-surface-structures
  • Press release - 22/02/2010 10826_de.jpg

    AgenoLab GmbH: Improved quality of life for patients with chronic wounds

    Since its foundation three years ago, AgenoLab GmbH & Co. KG in Stuttgart has become a leading service provider in the area of life sciences and biotechnology. The company’s cell culture technology unit focuses on the preparation of cells that can largely eliminate the need for animal testing. In the area of regenerative medicine, AgenoLab GmbH concentrates on the growth of skin cells as transplants for patients suffering from burns and…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/agenolab-gmbh-improved-quality-of-life-for-patients-with-chronic-wounds
  • Article - 11/02/2010 10687_de.jpg

    Johanna Schanz: Liver model as an alternative to animal experiments

    Blood vessels of a piece of pig’s intestine are used as carrier material for the IGB’s liver model and the cells seeded on the blood vessels stem from human biopsies. Dr. Johanna Schanz from the Fraunhofer IGB used this combination to produce her doctoral thesis which led to impressive results: a functional system of blood vessels in a biological carrier structure. Schanz’s outstanding thesis results have led to the creation of a liver model for…

    https://www.gesundheitsindustrie-bw.de/en/article/news/johanna-schanz-liver-model-as-an-alternative-to-animal-experiments
  • Article - 28/01/2010 10612_de.jpg

    Liver cell transplantation for the treatment of innate urea cycle defects

    Liver transplantation is the only life-saving therapy available to patients suffering from genetic defects of the urea cycle. However, newborns cannot be transplanted with a donor liver. The injection of liver cell suspensions into the liver of sick babies through the portal vein can substitute the lack of enzyme activity, hence preventing brain damage until such time as liver transplantation becomes possible.

    https://www.gesundheitsindustrie-bw.de/en/article/news/liver-cell-transplantation-for-the-treatment-of-innate-urea-cycle-defects
  • Article - 25/01/2010 Prof. Dr. Martin Elmlinger and his colleague Marion Eisenhauer in the laboratory. Elmlinger is holding a ball-pen in his hand, pointing at a microtitre plate Marion Eisenhauer is holding in her hand.<br />

    Intelligent use of suitable biomarkers

    How quickly does a pharmaceutical substance exert its effect? What mechanisms does it use to exert its effect on people and how long does it remain active? In a team headed by Prof. Dr. Martin Elmlinger Nycomed GmbH has developed an efficient biomarker discovery concept specially adapted to the companys requirements and designed to clarify such questions. The concept is specifically geared to the phases and requirements of the companys projects.…

    https://www.gesundheitsindustrie-bw.de/en/article/news/intelligent-use-of-suitable-biomarkers
  • Article - 14/12/2009 10386_de.jpg

    Clever surveillance system keeps yeast in check

    The spectrum of human diseases (mycoses) caused by fungi ranges from trivial nail infections to life-threatening systemic infections. The latter are mainly caused by Candida albicans. The dermatologist Prof. Dr. med. Martin Schaller from Tübingen is investigating how this fungus, which is actually part of the normal microbial flora of humans, becomes a pathogen. At the same time, he is looking into the role the patient’s immune system plays in…

    https://www.gesundheitsindustrie-bw.de/en/article/news/clever-surveillance-system-keeps-yeast-in-check
  • Article - 28/10/2009 09928_de.jpg

    Worn down and financially exhausted, but more popular than ever

    When academic toxicologists in a German state join forces, it is virtually headline news. This is because the discipline is on the red list. Only in Baden-Württemberg does the number of toxicologists at university institutes justify the joining of forces. The ironic thing about this is that the competence of the rare species ”toxicologicus” is in greater demand than ever.

    https://www.gesundheitsindustrie-bw.de/en/article/news/worn-down-and-financially-exhausted-but-more-popular-than-ever
  • Press release - 16/09/2009 Portrait of professor doctor Lutz Claes.

    Praise and prize for researchers from Ulm

    Three prizes have recently been awarded to researchers for their outstanding achievements in the research of methods that help reduce the number of animal experiments conducted, contribute to elucidating cellular processes and improve patient treatment. This article features the three prizewinners and their achievements.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/praise-and-prize-for-researchers-from-ulm
  • Press release - 15/09/2009 09645_de.jpg

    Nose drops rather than transplantation – an alternative and complementary method to animal testing

    On 14th September 2009 the physician Dr. Lusine Danielyan from Tübingen was awarded the Förderpreis Ersatz- und Ergänzungsmethoden zum Tierversuch des Landes Baden-Württemberg Prize for alternative and complementary methods to animal testing in Stuttgart. The young scientist who works in the Department of Clinical Pharmacology at the Institute of Experimental and Clinical Pharmacology and Toxicology at the University Hospital of Tübingen has…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/nose-drops-rather-than-transplantation-an-alternative-and-complementary-method-to-animal-testing
  • Press release - 08/09/2009 The photo shows a chicken egg model used to examine vascularistion in tissue engineering.

    Angiogenesis as a key for tissue engineering

    The German Research Foundation is to fund a research priority of the Department of Plastic Surgery at the Freiburg University Medical Centre. Researchers around the world working in the area of regenerative medicine are all equally hopeful of generating tissue replacements using modern tissue engineering. The development of tissue cells on carrier materials seems quite promising. However, tissue-engineered implants are often rejected by patients…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/angiogenesis-as-a-key-for-tissue-engineering
  • Dossier - 26/08/2009 20433_de.jpg

    Model organisms

    Given that everything is very individual in nature, how can a biologist come up with general statements about how life functions? The answers can only be found using models that represent the entire whole. Modern research uses representative species from the kingdom of bacteria, fungi, plants and animals to glean information about fundamental biological principles. How can the knowledge gained be transferred to other organisms, including humans?…

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/model-organisms
  • Article - 21/08/2009 09395_de.jpg

    Patenting and clinical trials go hand in hand

    Back when he was doing his degree thesis at the German Cancer Research Centre in Heidelberg the immunologist Prof. Peter Öhlschläger who now works at the University of Constance laid down the basic principles for developing an artificial gene for the treatment of cervical cancer. Prof. Öhlschläger is currently in the process of filing a patent for DNA vaccines for HPV. In the following interview the scientist says that the greatest challenges are…

    https://www.gesundheitsindustrie-bw.de/en/article/news/patenting-and-clinical-trials-go-hand-in-hand
  • Article - 30/06/2009 Following the treatment of a patient with cytochrome P450-inducing anti-epileptic drugs (in this case, carbamazepin), the quantity of androgen receptors (green) considerably increases.

    More targeted treatment of the brain network

    “Casting out the demons with the ruler of the demons” – is what the majority of neuroactive drugs still do. A group under the leadership of Dr. Ralf Meyer at the University Medical Centre in Freiburg is investigating why substances used to treat epilepsy or depression have a negative effect on many patients. Their research shows that the drugs interact with the hormonal system, resulting in undesired side effects. Meyer and his team of…

    https://www.gesundheitsindustrie-bw.de/en/article/news/more-targeted-treatment-of-the-brain-network
  • Press release - 24/06/2009 08916_de.jpg

    Artificial liver for drug testing

    The liver is one of the most important metabolic organs in humans. Johanna Schanz and Heike Mertsching, two scientists from Fraunhofer have developed a model of the liver that is both viable outside the body and suitable for testing drugs. For their work, the two researchers have been awarded the Technology for People award, along with a cheque for 10,000 euros.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/artificial-liver-for-drug-testing
  • Press release - 22/06/2009 08887_de.jpg

    Many animal experiments are superfluous

    Researchers at the Esslingen University of Applied Sciences are working on an alternative to the large number of animal experiments that are still being carried out. Researchers under the leadership of Prof. Dr. Bettina Weiß have received a grant from the Landesstiftung Baden-Württemberg foundation for work on this particular research area.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/many-animal-experiments-are-superfluous
  • Article - 05/04/2009 08322_de.jpg

    JOTEC – artificial blood vessel specialist

    JOTEC GmbH a medical device company based in Hechingen has a broad range of solutions on offer for the therapy of vascular diseases including artificial blood vessels and stentgrafts and is an international leader in this field. The company not only produces traditional vascular grafts from high-quality plastics but also absorbable bioartificial vascular grafts and cell-coated grafts made from biomaterials. Such an approach is currently unique in…

    https://www.gesundheitsindustrie-bw.de/en/article/news/jotec-artificial-blood-vessel-specialist
  • Article - 10/02/2009 08013_de.jpg

    Janine Reis – improving the acquisition of motor skills

    Putting a teaspoon of sugar into a cup of coffee would appear to be a very trivial action. However the coordination of hand and fingers becomes a virtually insurmountable challenge for people who have suffered a stroke. Dr. Janine Reis assistant doctor and researcher in the Department of Neurology at the Freiburg Medical School is investigating ways to improve the acquisition of fine motor skills.

    https://www.gesundheitsindustrie-bw.de/en/article/news/janine-reis-improving-the-acquisition-of-motor-skills
  • Article - 02/02/2009

    CureVac enters premier biotech league with new cancer vaccine

    At present active immunotherapy seems to produce the best results in the treatment of cancer. The Tübingen-based biotech company CureVac is now hoping to achieve a breakthrough in cancer therapy with a worldwide unique vaccine. The first clinical trials have recently commenced.

    https://www.gesundheitsindustrie-bw.de/en/article/news/curevac-enters-premier-biotech-league-with-new-cancer-vaccine
  • Press release - 08/01/2009 The photo shows an opened chicken egg.<br />

    ILM – Alternative models to replace animal experiments

    Since the beginning of the last century, fertilised chicken eggs have been an established model system and are nowadays often used as an alternative to animal experiments. The test model involves the use of the outer, strongly vascularised amnion (the so-called chorioallantoic membrane, CAM) which surrounds the embryo and is used for gas exchange during embryonic development.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/ilm-alternative-models-to-replace-animal-experiments
  • Article - 07/12/2008

    Production line for artificial skin

    A fully automated process is set to improve the production of artificial tissue medical scientists can perform transplants with skin produced in the laboratory. This tissue is also suitable for testing chemicals at a low cost without requiring animal experiments.

    https://www.gesundheitsindustrie-bw.de/en/article/news/production-line-for-artificial-skin
  • Article - 19/11/2008

    cr.appliance- integrated concepts in drug development

    Karen Grave-Hermann and Dr. Robert Hermann founded cr.applications in 2003. The two specialists who have wide-ranging experience in drug development talked to Michael Statnik about current trends in their field and about the development of the German biotech sector.

    https://www.gesundheitsindustrie-bw.de/en/article/news/cr-appliance-integrated-concepts-in-drug-development

Page 3 / 4

sb_search.block.search_result.other.pages

  • eine Seite vor
  • 1
  • 2
  • 3
  • 4
  • eine Seite zurück
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • Telemedicine BW
    • MDR & IVDR
  • Portals
    • BIOPRO BW
    • Healthcare industry
    • Bioeconomy
  • To top

stay informed

Subscribe to newsletter

Social Media

  • Xing
  • Twitter
  • LinkedIn
  • Rss
  • Privacy statement
  • Legal notice
  • Sitemap
  • Contact
© 2022
Website address: https://www.gesundheitsindustrie-bw.de/en/search